TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | 6 | 1 | -1 | -14 | -22 | -5 |
| P | %wins | 50 | 100 | 50 | 50 | 50 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/16/08 13:38 | 9/12/08 | NXXI | Nutrition 21 Inc | NY | Health | BioPrd | Biological Products, (No Diag | Mann Peter | NY | D | P.m | 25 | 0.3605 | 0 | 70 | 54 | 200 | D | |||||||||||||||
5/14/08 15:50 | 5/14/08 | NXXI | Nutrition 21 Inc | NY | Health | BioPrd | Biological Products, (No Diag | Mann Peter | NY | D | P | 12 | 0.4000 | 0 | 30 | 30 | 130 | D | |||||||||||||||
11/21/07 14:51 | 11/21/07 | NXXI | Nutrition 21 Inc | NY | Health | BioPrd | Biological Products, (No Diag | Mann Peter | NY | D | P | 71 | 0.7099 | 0 | 100 | New | 100 | D | |||||||||||||||
9/22/05 17:32 | 9/21/05 | PBH | Prestige Brands Holdings, Inc. | Health | Drug | Pharmaceutical Preparations | Mann Peter | NY | DO | CEO | P | 179 | 11.90 | 3 | 15 | 2 | 832 | D | -35 | -37 | -8 | -10 | -5 | -2 | 7 | 7 | 3 | 2 | 3 | -3 | |||
2/14/05 20:49 | 2/10/05 | PBH | Prestige Brands Holdings, Inc. | Health | Drug | Pharmaceutical Preparations | Mann Peter | NY | DO | CEO | P | 2 | 17.50 | 33 | 0 | 0 | 1,121 | D | -1 | 4 | -2 | -3 | -30 | -41 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |